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Abstract 
  
Background 
Legislation and practice of involuntary hospital admission vary substantially among 
European countries, but differences in outcomes have not been studied.  
 
Aims 
To explore outcomes following involuntary hospitalisation in different European 
countries.  
 
Method  
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In a prospective study in 11 countries 2326 consecutive involuntary patients admitted 
to psychiatric hospital departments were interviewed within one week after 
admission; 1809 were followed-up one month and 1613 three months later. Patients’ 
views as to whether the admission was right were the outcome criterion. 
 
Results 
In the different countries, between 39% and 71% found the admission right after one 
month, and between 46% and 86% after three months. Female patients, those living 
alone and those with a diagnosis of schizophrenia had more negative views. Adjusting 
for confounding factors, differences between countries were significant.  
 
Conclusions  
International differences in legislation and practice may be relevant for outcomes and 
inform improvements of policies, particularly in countries with poorer outcomes.  
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Introduction 
 
Throughout the world significant numbers of patients are involuntarily admitted to 
psychiatric hospital departments. How involuntary hospital admissions should best be 
legislated for and regulated, has been controversial 1–3.  In the United Kingdom, the 
government has proposed two bills for a new mental health act in England and Wales 
since 2002. Following wide resistance of professional groups, user organisations and 
part of the media, both bills were withdrawn and the government settled for an 
amendment of the existing 1983 Act 4,5.   
 
The debate on the most appropriate regulations and practice of involuntary hospital 
admission is guided by little, if any, research. There is no evidence on whether 
specific procedures are associated with different outcomes 6,7. Ethical and practical 
reasons may prevent experimental designs such as randomised controlled trials.  In 
their absence, observational comparisons between sites with different legislation and 
practice are a viable method to explore the link between procedures and outcomes.  
 
Countries across Europe share a similar background in terms of societal systems and 
history of psychiatry, but vary substantially in their legislation for and practice of 
involuntary hospital admission 8,9. Involuntary admission rates vary by a factor of 
more than 10 1,10. Several studies have analysed the differences in legislation and 
policies but there is no evidence yet on whether there also are differences in 
outcomes.  
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Legislation for involuntary admissions is based on the assumption that patients cannot 
recognise the need for hospital care because of the severe and usually acute symptoms 
of their illness.  This would imply that patients should later (once the acute phase is 
over) accept that the involuntary admission was the right intervention at the time 11.  
Patients’ retrospective view of the appropriateness of the admission has been used as 
an outcome criterion in studies in Australia, Canada, Sweden, the United States and 
the United Kingdom 12–18. Between 33% and 81% of involuntary patients found the 
admission “right” in retrospect. The rate varied according to the exact wording of the 
question and the time since admission 6.   
 
In this study we assessed patients’ views of involuntary hospital admission after one 
and three months at sites in eleven European countries.  We explored whether and, if 
so, to what extent patients’ retrospective views of admission vary between sites in 
different countries and whether these differences hold true after controlling for 
differences in patient characteristics. 
  
Methods 
 
Design and participants 
 
The study was conducted as a multi-centre prospective cohort study in eleven 
European countries, Bulgaria (Sofia), Czech Republic (Prague), Germany (Dresden), 
Greece (Thessaloniki), Italy (Naples), Lithuania (Vilnius), Poland (Wroclaw), 
Slovakia (Michalovce), Spain (Granada and Malaga), Sweden (Örebro), and the 
United Kingdom (East London). Between one and five hospitals were studied in each 
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country. Tel Aviv in Israel was originally included, but omitted from this analysis 
because of inadequate study implementation. All sites had in-patient units with 
voluntary as well as involuntary patients. Involuntary admissions were conducted 
according to national legislation and routine practice. The rationale and methods of 
the study, the characteristics of the participating hospitals and data of other mental 
health services in the catchment areas of the hospitals have been described in detail 
elsewhere 19. The inclusion criteria were: all in-patients in general psychiatric 
departments; admitted involuntarily; aged between 18 and 65 years; resident in the 
catchment area; sufficient command of the national language; able to give informed 
consent. Exclusion criteria were: Admission because of intoxication; primary 
diagnosis of dementia; transfer from another hospital. 
 
Procedures and measures 
 
Patients were identified by researchers through ongoing contacts with clinical staff on 
the wards and the relevant administrators. Clinical staff in the participating wards 
introduced eligible patients to a researcher, who contacted the patient within the first 
week after admission, provided a full explanation of the study, and asked for consent. 
If written informed consent was obtained, the patient was assessed. This included an 
assessment of psychopathological symptoms, which were taken as baseline symptom 
levels. Further face to face interviews were conducted at follow-ups at one month and 
three month after the admission. Patients were recruited between July 2003 and 
October 2005. 
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The primary outcome was the patients’ retrospective view on the extent to which the 
admission was right or wrong at one and three months. Patients rated their response to 
the question “Today, do you find it right or wrong that you were admitted to 
hospital?” on an 11 point Likert type rating scale ranging from 0 (=entirely wrong) to 
10 (=entirely right), which has been used in previous research 14,15.  
 
Baseline socio-demographic and clinical characteristics and the diagnosis of the 
patients were obtained from medical records. These included data on age, gender, 
living situation (living alone vs. living with others), employment situation (no current 
employment vs. employment), previous hospitalisations (none vs. one or more 
previous hospitalisations), and clinical diagnosis according to ICD-10 20. Diagnoses 
were collapsed into three groups: schizophrenia or other psychosis (F20-29), affective 
disorder (F30-39), and ‘others’. Researchers assessed baseline symptom levels on the 
24-item version of the Brief Psychiatric Rating Scale (BPRS 21) which ranges from 24 
to 168, with 168 indicating the maximum symptom severity. Researchers from all 
sites had joint training sessions in administering and rating this instrument and 
achieved an inter-rater reliability (intra-class correlation coefficient) of 0.78. The 
study was approved by the relevant national and/or local ethics committees. 
 
Statistical analysis 
 
The outcome variable was the patients’ retrospective view on the extent to which the 
admission was right or wrong on an 11 point scale (0=entirely wrong, 10=entirely 
right), and was treated as quantitative in the analysis to fully utilise the variation of 
patient’s responses and summarised by mean and standard deviation after examining 
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its distribution. To present the primary outcome in each country in a clinically more 
meaningful manner, we also dichotomised the scale at 5 (the neutral middle point) and 
show the percentage of patients who rated above 5 indicating that they viewed their 
admission as more right than wrong. Descriptive summary statistics were also used to 
describe the distributions of the predictors of the outcome variable.   
 
To account for possible correlations among repeated measurements, a generalised 
estimating equation (GEE) model was employed 22 with patients’ characteristics 
measured at baseline and time of measurement as fixed effects and subject as random 
effect. We performed GEE model analysis in three steps. First, we performed a 
univariate GEE model analysis for all predictors. Predictor variables that were 
significant at P=0.05 were subsequently entered in a multivariate GEE model analysis 
in the second step. Finally, we checked model assumptions by examining the residual 
plots. 
 
The estimated effects of predictors on the primary outcome from the GEE models are 
reported together with their 95% confidence intervals. To identify the between 
country differences, we derived a matrix of P-values for all possible pair-wise 
between-country comparisons from the estimated multivariate GEE model.  
 
In England, age, gender, and clinical diagnosis were obtained for all eligible patients 
in the study including those who were not interviewed (approved by the Patient 
Information Advisory Group; ref: PIAG 2-10(d)/2005). Interviewed and not 
interviewed patients were compared on the assessed characteristics to estimate a 
potential selection bias of the recruitment process.  
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Results 
 
Sample characteristics 
 
A total of 2326 patients were recruited in all countries and assessed at baseline. Table 
1 shows the number of eligible patients and the selection process in each country. 
 
Table 1 about here 
 
Between 31% and 71% of eligible patients were interviewed within the first week of 
admission, and of these between 63% and 96% were followed up at one month and 
between 55% and 93% at three months. 
 
The characteristics of the participating patients are summarised in Table 2.  
 
Table 2 about here 
 
Overall, 72% of patients were without employment, 66% lived alone, 71% had been 
hospitalised before, and 62% were diagnosed with schizophrenia.   
 
At the English site, baseline data was obtained for 181 out of those 183 patients who 
were eligible but not interviewed. Their mean age was 36.01 (SD=11.41). Of these 
40% were female, 60% diagnosed with schizophrenia, 22% with affective disorders, 
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and 18% with ‘other’ diagnoses. The interviewed and non-interviewed patients were 
similar on the tested characteristics listed in Table 2. 
 
The baseline characteristics of patients in the total sample followed-up at one month 
(and at three months) were: 45.1% (45.5%) female; 73.1% (72.2%) unemployed; 
35.3% (36.0%) living with others; 71.4% (72.3%) with a previous hospitalisation; 
65.7% (64.7%) diagnosed with schizophrenia, 16.7% (17.2%) with affective 
disorders, and 17.6% (18.1%) with ‘other’ diagnoses. The mean age of those 
followed-up at one month was 38.87 (SD=11.21), and of those followed-up at three 
months 39.10 years (SD= 11.13). The baseline BPRS mean score of those followed up 
at three months was 54.77 (SD=15.84) and of those followed-up at three month 55.08 
(SD=15.84). The assessed characteristics of the originally recruited sample, and the 
samples followed-up at one and three months were similar. 
 
Patients’ views on whether admission was right  
 
Table 3 shows the percentage of patients who thought that the admission was right as 
well as the means and standard deviations of their ratings for each country and each 
follow-up. 
 
Table 3 about here  
 
In the total sample, 55% thought at one month that their admission was right and 63% 
at three months. The percentages varied between 39% and 71% at one month, and 
between 46% and 86% at three months.  
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Across all countries, the distribution of the scores of the 11-point rating scale were at 
one month (and three month): 0=17% (13), 1=3% (2), 2=5% (4), 3=4% (5), 4=3%(3), 
5=12%(11), 6=5%(5), 7=8%(9), 8=12%(13), 9=9%(12), 10=22%(24).  
 
Factors associated with patients’ views  
 
The univariate associations of all considered predictor variables including country of 
site with the outcome and the findings of the multivariate analysis are shown in Table 
4. Table 5 shows which differences between countries were significant in pair-wise 
post-hoc comparisons, adjusting for the influence of all other significant predictor 
variables. 
 
Table 4 about here 
 
Table 5 about here 
 
Patients’ views on the appropriateness of their involuntary admission show significant 
differences between sites in different countries, even when adjusted for other 
predictor variables. The post-hoc comparisons show that not all differences between 
sites at different countries were statistically significant, but the more substantial ones 
were. For example, the patients’ views in England are significantly less favourable 
than those in Bulgaria, Greece, Spain, the Czech Republic, Italy, Germany, and 
Slovakia, whilst patients’ views in Slovakia are significantly more positive than in all 
sites other than those in the Czech Republic, Italy and Germany. 
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All further considered predictor variables other than previous hospitalisation showed 
significant associations with outcomes in univariate analyses. In the multivariate 
analysis however, only gender, living situation and diagnosis were significantly 
associated with patients’ views. Male patients and those living with others tended to 
find the admission more often right. Patients with schizophrenia had more negative 
views than those with other diagnoses.  
 
Discussion 
 
Main findings 
 
One month after involuntary hospital admission, between 39% and 71% believe the 
admission was right. After three months, when the acute phase of the mental illness 
justifying the involuntary admission should be overcome for most patients, the rates 
are higher and range between 46% and 86%. The findings that a substantial 
proportion of patients do retrospectively not agree with the appropriateness of the 
admission may shed a critical light on the ethical justification of involuntary hospital 
admission. At the same time, an average of 63% found the admission right three 
months later which may be a reassuring finding to many clinicians, patients and their 
families.  The figures are consistent with previous studies with smaller samples and 
usually less systematic methods 6,14,23,24. However what is a totally new finding is the 
large variation across sites in different European countries. This variation is not 
explained by differences in socio-demographic characteristics, clinical diagnoses or 
baseline symptom levels included in this study. The size of the differences is 
substantial, and many of them are statistically significant. 
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Strengths and limitations 
 
This is the largest prospective study on outcomes of involuntary hospital admissions 
ever conducted and the first one to use the same methods across sites in several 
countries. It included centres in eleven European countries with different legislation 
and practice of involuntary admission. All patients were assessed face to face by 
trained researchers, and were recruited and interviewed within the first week after 
admission, which is challenging given that many patients had high symptom levels 
and all of them were in the hospital on an involuntary basis.  
 
The study has a number of weaknesses: Overall only 50% of the eligible patients were 
interviewed, a rate that varied across countries. The rate may be seen as low in many 
other fields of health research, but has been described as good for this type of studies 
in acute settings with difficult to recruit patients 6. For the comparison of recruited and 
non-recruited patients data were available only for the English site, whilst the 
followed up and not followed up patients were compared at all sites. These 
comparisons did not suggest a selection bias on the assessed characteristics, neither 
for the recruitment of eligible patients nor for the follow ups. However, only a few 
characteristics were assessed.  
 
We assessed only between one to five hospitals in each country and do not know to 
what extent the data is representative for the country as a whole. In England we have 
data of a linked national study to estimate this 24. The study sites were two hospitals in 
the London Boroughs of Hackney and Newham. In 20 other hospitals, the same 
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outcome data were assessed in 371 involuntary patients at one month and in 307 
patients at three months. At one month, 45% (166) of patients felt that the admission 
was rather right (mean=4.81; SD=3.99), and at three months 50% (154) expressed that 
view (mean=5.34; SD=3.94). Outcomes at the two hospitals of the study site in East 
London and 20 other hospitals in England were similar, and using the data of those 20 
hospitals would not have substantially changed the findings of the national 
comparisons. However, there is no similar data from other countries to check whether 
the results at the study sites are representative for or different from the outcomes at 
other hospitals in the country.  
 
Possible reasons for the differences 
 
Can the identified differences of patients’ views of involuntary admission be linked to 
characteristics of the given legislation? There is no straightforward answer. The 
legislation in all countries is complex and has many features which are of potential 
importance. Any interpretation of the findings of the identified differences against the 
characteristics of the national legislation is a post-hoc exercise and inevitably 
speculative.  
 
One possible criterion to classify the national regulations is the extent to which they 
protect the rights and interests of the patients concerned 8,9. Seven criteria that vary 
between countries and may be seen as relevant for the protection of the interests of the 
patients are shown in Box 1. Although the answers to the questions are not always 
clear cut, we established the number of criteria for each country. The resulting ranking 
has similarities with the order of outcomes in the multivariate analysis of this study 
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(with the most protective legislation and most positive patient views in Slovakia and 
Germany, and the least protective legislation and most negative views in England), 
but the criteria still leave many of the differences in patients’ views unexplained.  
 
Box 1 about here 
 
A number of other national features might be important. These include the 
geographical position and political history (e.g. Western vs. Eastern Europe), the 
relative expenditure of health care funding on mental health care 25, the overall rates 
of involuntary admissions 2, and the recruitment and follow-up rates in this study. 
However, none of these was clearly associated in our study with the differences 
identified in patients’ views. There are three other possible factors accounting for the 
differences that were not assessed. Firstly, patients at the various sites may have 
differed in relevant social or clinical characteristics that were not captured in the 
study. Secondly, national differences in the expectations of patients and overall rating 
tendencies may have favoured more or less positive answers to the outcome question. 
Finally, clinical practice (the behaviour of professionals towards involuntary patients 
and the methods employed to support and treat them) is likely to vary across Europe 
and impact on outcomes. Some aspects of clinical practice may be linked to national 
cultures and traditions and difficult to change, but others may reflect training and 
policies that are transferable to other countries.  
 
Factors associated with outcomes across countries 
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Some patient characteristics were associated with views of admission across 
countries. Females expressed more negative views, as has been reported for other 
patient reported outcomes in psychiatry, although not a consistent finding 26,27. 
Patients living alone more often rated the admission as wrong, which may reflect their 
difficulties adjusting to the confined space and the often tense atmosphere with fellow 
patients and staff on a ward. It may also be that patients living with others had often 
experienced conflicts and tension with these making the admission a relief and 
therefore right in retrospect. During and after hospital treatment they are likely to 
have had discussions with their partners about their illness and received support from 
them. Both discussions and support may have led to more positive appraisals of the 
admission. Patients with schizophrenia had more negative views of admission, which 
may be linked to more frequent lack of insight in these patients 28. In the multivariate 
analysis, the degree of baseline symptoms was not associated with later views of the 
admission. Thus, this study provides no evidence for the assumption that a high level 
of initial symptoms is associated with more negative views of admission later.  
  
Conclusions 
 
The findings suggest that the great differences of legislation and practice of 
involuntary hospital admission and subsequent treatment across Europe may indeed 
be associated with substantial differences in patients’ views. Although the exact 
causal factors and mechanisms remain poorly understood, the differences between 
European countries appear to matter for outcome 29. Future in-depth studies could 
identify those factors in legislation and practice that are specifically relevant for 
achieving more positive views of patients 30. Countries with currently less favourable 
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outcomes, such as England, might consider implementing them, and methods may be 
developed to strengthen these factors and improve outcomes across all countries.  
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Table 1. Recruitment and follow-up rates at sites in all countries  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Bulgar
ia 
Czech 
Republic 
England Germany Greece Italy Lithuania Poland Slovakia Spain Sweden Total 
sample 
Eligible patients 475 581 451 466 349 280 120 334 439 850 306 4651 
Absconded/ 
discharged 
27 80 30 186 58 7 1 30 41 219 49 728 
Clinically too 
unwell 
76 160 89 59 43 60 17 52 87 84 44 771 
Asked to take part 372 341 332 221 248 213 102 252 311 547 213 3152 
Refused to take 
part 
63 139 64 76 26 84 17 100 15 126 116 826 
Assessed at 
baseline 
309 202 268 145 222 129 85 152 296 421 97 2326 
% of eligible 
patients 
65% 35% 59% 31% 64% 46% 71% 46% 67% 50% 32% 50% 
Assessed at 1 
month follow-up 
297 165 179 120 178 116 66 141 221 264 62 1809 
% of participants 
at baseline 
96% 82% 67% 83% 80% 90% 78% 93% 75% 63% 64% 78% 
Assessed at 3 
months follow-up 
287 146 175 106 147 111 48 140 162 236 55 1613 
% of participants 
at baseline 
93% 72% 65% 73% 66% 86% 56% 92% 55% 56% 57% 69% 
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Table 2. Baseline characteristics of participating patients at sites in all countries and hospitalisation status at one month and three month follow ups 
 Bulgaria 
N= 309 
 
N (%) 
Czech 
republic 
N= 202 
N (%) 
England 
N= 268 
 
N (%) 
Germany 
N= 145 
 
N (%) 
Greece 
N= 222 
 
N (%) 
Italy 
N= 129 
 
N (%) 
Lithuania 
N= 85 
 
N (%) 
Poland 
N= 152 
 
N (%) 
Slovakia 
N= 296 
 
N (%) 
Spain 
N= 421 
 
N (%) 
Sweden 
N= 97 
 
N (%) 
Total 
sample 
N= 2326 
N (%) 
Gender             
          Female 195 (63) 108 (53) 86  (32) 55 (38) 72 (32) 45 (35) 46 (54) 80  (53) 117 (40) 146 (35) 51 (53) 1001 (43) 
          Male 114  (37) 94   (47) 181 (68) 90  (62) 150 (68) 82  (65) 39  (46) 72   (47) 179 (60) 275 (65) 46  (47) 1322 (57) 
Age             
          N 309 202 265 145 222 127 85 152 296 421 97 2321 
          Mean       
          (SD) 
39.15 
(10.24) 
40.33 
(13.26) 
34.72 
(9.73) 
37.35 
(11.68) 
38.75 
(10.29) 
39.04 
(10.32) 
40.48 
(11.67) 
41.79 
(11.71) 
39.78 
(10.47) 
37.73 
(11.08) 
41.30 
(11.92) 
38.72 
(11.12) 
Employment             
          No 255 (87) 123 (61) 216 (82) 107 (74) 127 (57) 87 (69) 62 (73) 116 (77) 227 (77) 272 (66) 69 (71) 1661 (72) 
          Yes 37 (13) 78 (39) 47 (18) 38 (26) 95 (43) 39 (31) 23 (27) 35 (23) 69 (23) 143 (34) 28 (29) 632 (28) 
Living situation             
          With others 124 (41) 84 (42) 65 (25) 47 (32) 55 (25) 36 (29) 33 (40) 67 (44) 132 (45) 106 (25) 29 (31) 778 (34) 
          Alone 170 (58) 117 (58) 191 (75) 98 (68) 166 (75) 88 (71) 50 (60) 84 (56) 163 (55) 313 (75) 66 (69) 1506 (66) 
Past hospitalisation             
          At least one 236 (80) 148 (74) 193 (72) 104 (72) 137 (63) 93 (76) 71 (86) 99 (65) 175 (61) 269 (65) 82 (88) 1607 (71) 
          None  60 (20) 52 (26) 74 (28) 41 (28) 81 (37) 29 (24) 12 (14) 53 (35) 112 (39) 143 (35) 11 (12) 668 (29) 
Diagnosis             
          Schizophrenia 249 (90) 120 (60) 154 (59) 67 (46) 161 (73) 85 (67) 78 (92) 108 (71) 143 (48) 225 (53) 38 (40) 1428 (62) 
         Affective dis. 24 (9) 25 (12) 61 (23) 31 (21) 28 (13) 25 (20) 2 (2) 23 (15) 19 (6) 95 (23) 29 (31) 362 (16) 
          Other  5 (2) 57 (28) 47 (18) 47 (32) 33 (15) 17 (13) 5 (6) 21 (14) 134 (45) 101 (24) 28 (29) 495 (22) 
Symptoms (BPRS)             
          N 309 201 264 144 209 126 85 152 296 415 94 2295 
          Mean  
          (SD) 
69.09 
(13.99) 
50.23 
(13.41) 
51.26 
(10.85) 
54.25 
(12.71) 
48.55 
(10.37) 
73.16 
(21.11) 
58.23 
(10.94) 
47.98 
(11.55) 
49.94 
(13.06) 
45.30 
(10.83) 
48.36 
(10.82) 
53.39 
(15.36) 
Still in hospital at 1 
month 
222 (75) 105 (62) 116 (50) 91 (72) 113 (57) 5 (5) 64 (81) 105 (73) 177 (61) 35 (9) 27 (37) 1060 (50) 
Still in hospital at 3 
months 
135 (47) 16 (11) 36 (17) 21 (19) 17 (10) 3 (3) 16 (27) 10 (7) 8 (3) 3 (1) 12 (16) 274 (14) 
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Table 3. Patients’ views on whether admission was right or wrong at sites in all countries 
 
Patients’ views of 
admission 
Bulgaria Czech 
Republic 
England Germany Greece Italy Lithuania Poland Slovakia Spain Sweden Total 
sample 
1 month follow-up              
             N 284 159 176 118 163 112 66 138 204 253 59 1732 
             Mean  
             (SD) 
4.76 
(3.31) 
6.09 
(3.54) 
4.89 
(3.91) 
6.46 
(3.44) 
5.49 
(4.07) 
6.48 
(1.81) 
4.33 
(3.71) 
5.10 
(3.84) 
7 
(3.85) 
6.51 
(3.24) 
6.11 
(3.81) 
5.77 
(3.63) 
            % wrong 55 43 53 36 52 29 61 51 33 38 42 45 
            % right 45 57 47 64 48 71 39 49 67 62 58 55 
3 months follow-up             
             N 265 112 175 105 134 102 45 137 144 224 54 1497 
             Mean  
             (SD) 
5.86 
(3.30) 
6.95 
(3.04) 
5.6  
(3.98) 
7.18 
(3.08) 
6.63 
(3.73) 
7.25 
(1.54) 
6  
(2.84) 
5.93 
(3.69) 
7.13 
(3.74) 
6.35 
(3.29) 
5.79 
(3.72) 
6.37 
(3.43) 
            % wrong 42 32 46 30 39 14 49 39 31 34 54 37 
            % right 58 68 54 70 61 86 51 61 69 66 46 63 
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Table 4. Factors associated with patients’ views of admission in univariate and multivariate GEE* analyses 
* GEE = Generalised Estimating Equation. **B= regression coefficient 
 
 
 
 
 
 
 
 
 
 
 
 
Predictor variables Univariate Analysis Multivariate Analysis 
 B** 95%   CI P-value B** 95%   CI P-value 
Country         
England 0.00    0.00    
Lithuania 
-0.10 -0.98 0.77 0.817 0.04 -0.84 0.93 0.923 
Poland  0.29 -0.37 0.96 0.391 0.25 -0.41 0.93 0.454 
Bulgaria  0.04 -0.51 0.60 0.882 0.64 0.02 1.27 0.041 
Sweden  0.77 -0.09 1.63 0.080 0.77 -0.11 1.65 0.086 
Greece  0.63 -0.00 1.27 0.051 0.61 -0.03 1.27 0.064 
Spain  1.26 0.69 1.83 <0.001 1.15 0.57 1.73 <0.001 
Czech Republic  1.22 0.57 1.88 <0.001 1.19 0.53 1.85 <0.001 
Italy  1.64 0.92 2.36 <0.001 1.47 0.70 2.24 <0.001 
Germany  1.49 0.79 2.19 <0.001 1.30 0.60 2.01 <0.001 
Slovakia 1.92 1.31 2.52 <0.001 1.74 1.13 2.36 <0.001 
Gender         
male vs female  0.77 0.47 1.06 <0.001 0.77 0.46 1.08 <0.001 
Employment         
employed vs unemployed 0.44 0.11 0.77 0.008 0.17 -0.16 0.51 0.307 
Living alone         
Yes vs no 
-0.56 -0.87 -0.26 <0.001 -0.69 -1.02 -0.37 <0.001 
Diagnosis         
Schizophrenia 0.00    0.00    
Affective disorder 0.70 0.30 1.10 0.001 0.60 0.19 1.01 0.004 
Other  0.84 0.45 1.22 <0.001 0.43 0.03 0.84 <0.001 
BPRS score 
-0.01 -0.01 -0.00 0.035 0.00 -0.00 0.01 0.517 
No past hospitalisation 0.17 -0.15 0.50 0.286     
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Table 5. P-values from pair-wise between-country comparisons derived from multivariate GEE* model  
 
 England Lithuania Poland Bulgaria Sweden Greece Spain Czech 
Republic 
Italy Germany 
Lithuania  0.923          
Poland  0.454 0.648         
Bulgaria  0.041 0.165 0.257        
Sweden  0.086 0.190 0.272 0.781       
Greece  0.064 0.213 0.311 0.932 0.738      
Spain  <0.001 0.012 0.005 0.100 0.376 0.082     
Czech 
Republic  
<0.001 0.013 0.009 0.102 0.363 0.097 0.909    
Italy  <0.001 0.004 0.004 0.021 0.170 0.036 0.419 0.497   
Germany  <0.001 0.008 0.006 0.059 0.264 0.064 0.659 0.759 0.694  
Slovakia  <0.001 <0.001 <0.001 <0.001 0.029 0.001 0.043 0.089 0.477 0.209 
 
* GEE = Generalised Estimating Equation 
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Box 1. Criteria to distinguish the legislation on involuntary hospital admission with respect to the protection of the interest of the patients (the first option in each question is 
seen as more protective of the interest of the patients) 
 
Legislation criteria 
1) Is involuntary admission possible only when patients pose a risk to themselves and/or others, or also to avoid a more general threat to the patients’ health?  
2) Can the admission be initiated only by authorities and medical doctors or also by other stakeholders?  
3)  Does involuntary admission require the decision of a court or not?  
4) Is the period of time for which the hospital can decide to keep patients involuntarily on the wards without a formal decision for involuntary treatment shorter or longer than 
24 hours?  
5) Is legal support guaranteed or not?  
6) With respect to appeal procedures to independent bodies, are there binding time periods for a response, and are people and/or institutions other than the patient authorised 
to appeal, or not?  
7) Is the decision for involuntary treatment measures separate from the decision for involuntary admission or not?  
Criteria protecting the interest of the patients in each country 
Seven: Germany (1-7) 
Five: Slovakia (1,3,4,6,7), Sweden (1,2,4,5,6) 
Four: Bulgaria (1,3,4,7), Czech Republic (1,3,4,7), Spain (3,4,5,7) 
Three: Italy (2,6,7), Poland (2,3,5), Lithuania (1,2,3) 
Two: Greece (3,6) 
One: England (5) 
 
 
 
